Cardioprotective effect of N-(benzo[d]oxazol-2-yl)-2-(5-bromo-2-oxoindolin-3-ylidene)hydrazinecarboxamide against doxorubicin induced cardiotoxicity in rats

被引：1
|
作者：
Reddy, A. Rama Narsimha [1 ]
Nagaraju, J. [1 ]
Rajyalaksmi, G. [2 ]
Sarangapani, M. [2 ]
机构：
[1] Vaageswari Coll Pharm, Dept Pharmacol, Karimnagar 505481, Andhra Pradesh, India
[2] Kakatiya Univ, Dept Pharmaceut Chem, Univ Coll Pharmaceut Sci, Waranagal 506001, Andhra Pradesh, India
来源：
TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY | 2012年 / 94卷 / 10期
关键词：
cardiotoxicity; N-(benzo[d]oxazol-2-yl)-2-(5-bromo-2-oxoindolin-3-ylidene)hydrazinecarboxamide; cardioprotective; doxorubicin; LDH; CK-MB; AST; TG;
D O I：
10.1080/02772248.2012.741335
中图分类号：
X [环境科学、安全科学];
学科分类号：
08 ; 0830 ;
摘要：
The present study was aimed to evaluate the cardioprotective activity of N-(benzo[d]oxazol-2-yl)-2-(5-bromo-2-oxoindolin-3-ylidene)hydrazinecarboxamide (coded as ARL) in rats. Doxorubicin (DOX) (15 mg kg(-1), i.p, single dose) was used to induce cardiotoxicity in rats. Four groups of female Wistar albino rats were used. Group 1 was used as control (0.5% CMC, oral); the other groups were treated with DOX (single i.p. dosage of 15 mg kg(-1)) or DOX plus compound ARL (50 or 100mg kg(-1) day(-1), p.o.), respectively. Animals were treated with ARL or CMC for 7 days. On 6th day, a single dose of DOX was administered to rats. Blood was collected on 7th day. Evaluation of cardioprotective activity was estimated using biochemical parameters including plasma aspartate aminotransferase, creatine kinase (CK-MB), lactate dehydrogenase (LDH), and triglycerides (TG) levels. Pretreatment with compound ARL significantly reduced the elevated levels of cardiotoxic biomarkers in plasma. DOX-induced depletion of glutathione levels in blood was significantly alleviated by pretreatment with compound ARL.
引用
收藏
页码：2012 / 2018
页数：7
相关论文
共 50 条
  • [31] The synthesis, crystal structure and Hirshfeld surface analysis of the thiophene derivatives 5-(phenylsulfonyl)-5,6-dihydrobenzo[4,5]thieno[3,2-j]phenanthridine and (E)-N-{2-[2-(benzo[b]thiophen-2-yl)ethenyl]phenyl}-N-(prop-2-yn-1-yl)benzenesulfonamide
    Madhan, S.
    NizamMohideen, M.
    Pavunkumar, Vinayagam
    MohanaKrishnan, Arasambattu K.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2023, 79 : 521 - +
  • [32] N-{2-[(4S)-4-tert-Butyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl}-5,6-diphenyl-1,2,4-triazin-3-amine
    Karczmarzyk, Zbigniew
    Wolinska, Ewa
    Fruzinski, Andrzej
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O651 - U2016
  • [33] Inhibitory effects of isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2-yl)carbamoyl]acetate (YH439) on benzo[a]pyrene-induced skin carcinogenesis and micronucleated reticulocyte formation in mice
    Surh, YJ
    Kim, SG
    Liem, A
    Lee, JW
    Miller, JA
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1999, 423 (1-2) : 149 - 153
  • [34] New 2-[(4-Amino-6-N-substituted-1,3,5-triazin-2-yl)methylthio]-N-(imidazolidin-2-ylidene)-4-chloro-5-methylbenzenesulfonamide Derivatives, Design, Synthesis and Anticancer Evaluation
    Tomorowicz, Lukasz
    Zolnowska, Beata
    Szafranski, Krzysztof
    Chojnacki, Jaroslaw
    Konopinski, Ryszard
    Grzybowska, Ewa A.
    Slawniski, Jaroslaw
    Kawiak, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [35] Crystal structure of (2E)-2-[3-(1H-imidazol-1-yl)-1-phenylpropylidene]- N-(4-methylphenyl)hydrazinecarboxamide, C20H21N5O
    Attia, Mohamed I.
    Ghabbour, Hazem A.
    Darwish, Hany W.
    Fun, Hoong-Kun
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2014, 229 (04): : 311 - 312
  • [36] Crystal structure of (2E)-2-[1-(4-bromophenyl)-3-(1H-imidazol-1-yl) propylidene]-N-(2,4-dichlorophenyl) hydrazinecarboxamide, C19H16BrCl2N5O
    Al-Wabli, Reem I.
    Attia, Mohamed I.
    Ghabbour, Hazem A.
    El-Sayed, Nahed N. E.
    Fun, Hoong-Kun
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2015, 230 (03): : 217 - 218
  • [37] Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D2 and 5-hydroxytryptamine 5HT1A receptors
    Sukalovic, Vladimir
    Ignjatovic, Djurdjica
    Tovilovic, Gordana
    Andric, Deana
    Shakib, Kaveh
    Kostic-Rajacic, Sladjana
    Soskic, Vukic
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) : 3967 - 3972
  • [38] Vinylene and benzo[c][1,2,5]thiadiazole: effect of the π-spacer unit on the properties of bis(2-oxoindolin-3-ylidene)-benzodifuran-dione containing polymers for n-channel organic field-effect transistors
    Thu Trang Do
    Patil, Basanagouda B.
    Singh, Samarendra P.
    Yambem, Soniya D.
    Feron, Krishna
    Ostrikov, Kostya
    Bell, John M.
    Sonar, Prashant
    RSC ADVANCES, 2018, 8 (68): : 38919 - 38928
  • [39] Regional hemodynamic effects of the N-(2-benzoylphenyl)-L-tyrosine peroxisome proliferator-activated receptor-γ ligand, GI 262570 [(S)-2-(2-benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic acid], in conscious rats
    Gardiner, SM
    Nunez, DJR
    Baer, PG
    Brown, KK
    Bennett, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (03): : 1226 - 1233
  • [40] Synthesis, characterization, biological evaluation and molecular docking studies of 2-(1H-benzo[d]imidazol-2-ylthio)-N-(substituted 4-oxothiazolidin-3-yl) acetamides
    Snehlata Yadav
    Balasubramanian Narasimhan
    Siong M. Lim
    Kalavathy Ramasamy
    Mani Vasudevan
    Syed Adnan Ali Shah
    Manikandan Selvaraj
    Chemistry Central Journal, 11
12345